
Pfizer's shares outstanding refer to the total number of outstanding shares of the company's common stock. This number is a key metric in understanding the company's capital structure and financial performance.
Pfizer's shares outstanding can fluctuate due to various factors, including stock splits and share buybacks. As of the most recent data, Pfizer's shares outstanding stood at approximately 4.3 billion.
Having a large number of shares outstanding can impact Pfizer's earnings per share (EPS) calculation. For example, if the company's net income remains constant, a higher number of shares outstanding would result in a lower EPS.
Share Statistics
Pfizer has a significant number of shares outstanding, with 5.67 billion shares in circulation.
The number of shares has decreased by -0.16% in the past year, indicating a slight decline in the company's share count.
The majority of these shares are held by institutions, with 68.37% of shares owned by institutional investors.
Here's a breakdown of the ownership structure:
The float, which represents the number of shares available for trading, is also significant, with 5.66 billion shares available.
Shares Outstanding
Shares Outstanding is a crucial metric to understand the financial health of a company. Pfizer has a significant number of shares outstanding, with 5.67 billion shares currently in circulation.
This number has decreased by 0.16% over the past year, which may indicate a reduction in the company's stock or a change in its ownership structure. I've seen similar fluctuations in stock prices before, and it's essential to keep an eye on these changes.
The majority of Pfizer's shares are held by institutions, which make up 68.37% of the total shares outstanding. This is not surprising, as institutional investors often have a significant presence in the stock market.
Here's a breakdown of Pfizer's shares outstanding:
It's worth noting that insiders own a relatively small percentage of Pfizer's shares, with only 0.03% being held by insiders. This suggests that the company's leadership may not have a significant stake in the company's stock.
Stock Price Statistics
When analyzing a stock's performance, it's essential to look at its price statistics.
Pfizer's stock price has decreased by -6.44% in the last 52 weeks.
This indicates a downward trend in the stock's value over the past year.
The beta, which measures price volatility, is 0.57, showing that Pfizer's price has been lower than the market average.
Here are the key stock price statistics:
Financial Information
Pfizer has a significant number of shares outstanding, totaling 5.67 billion.
The number of shares has decreased by 0.16% over the past year, indicating a slight decline in the company's share count.
The majority of Pfizer's shares are held by institutions, with 68.37% of the total shares outstanding.
Here's a breakdown of the ownership structure:
The float, which represents the number of shares available for public trading, is 5.66 billion, very close to the total number of shares outstanding.
Income Statement
Pfizer's income statement reveals a significant revenue of $63.63 billion in the last 12 months.
The company's revenue is substantial, with $63.63 billion generated in the last year. This is a notable figure that indicates the company's success in the market.
Pfizer's gross profit was $47.21 billion, which is a significant portion of their revenue. This suggests that the company has a strong pricing strategy and is able to maintain a healthy profit margin.
The company's operating income was $16.33 billion, which is a key indicator of their ability to generate profits from their core operations. This figure is also notable as it is equal to their EBIT (Earnings Before Interest and Taxes).
Here is a summary of Pfizer's key income statement figures:
Pfizer's net income was $8.03 billion, which is a significant figure that indicates the company's ability to generate profits.
Balance Sheet
The Balance Sheet is a crucial part of any company's financial information. It gives a snapshot of the company's liquidity and solvency.
The company in question has a significant amount of debt, with a total of $67.95 billion. This is a major concern for investors and creditors.
However, the company also has a substantial amount of cash, with $9.95 billion on hand. This can be used to pay off debt or invest in new opportunities.
The net cash position of the company is -$57.99 billion, which is a negative number. This means that the company's debts exceed its assets. The net cash per share is -$10.23, which indicates that each share of the company's stock is worth a loss of $10.23.
The company's equity, also known as its book value, is $92.56 billion. This represents the company's net worth and is calculated by subtracting liabilities from assets. The book value per share is $16.29, which is the company's net worth per share.
Here's a summary of the company's balance sheet:
Featured Images: pexels.com


